. "RIV/00064165:_____/13:10196616!RIV14-MZ0-00064165" . "In patients with MDS distinguish between high-and low-risk MDS using the International Prognostic Scoring System IPSS. The main problem is more or less symptomatic anemia."@en . "speci\u00E1ln\u00ED p\u0159\u00EDloha, leden" . "[DD9767C307F5]" . . . . "9" . "Terapie pacientky s myelodysplastick\u00FDm syndromem s p\u0159et\u00ED\u017Een\u00EDm \u017Eelezem peror\u00E1ln\u00EDm chel\u00E1torem deferasiroxem" . . "U pacient\u016F s MDS rozli\u0161ujeme vysoce a n\u00EDzce rizikov\u00E9 MDS s pou\u017Eit\u00EDm mezin\u00E1rodn\u00EDho prognostick\u00E9ho sk\u00F3rovac\u00EDho syst\u00E9mu IPSS. Hlavn\u00EDm probl\u00E9mem je v\u00EDce \u010Di m\u00E9n\u011B symptomatick\u00E1 anemie." . . "Farmakoterapie" . "CZ - \u010Cesk\u00E1 republika" . "1"^^ . "Terapie pacientky s myelodysplastick\u00FDm syndromem s p\u0159et\u00ED\u017Een\u00EDm \u017Eelezem peror\u00E1ln\u00EDm chel\u00E1torem deferasiroxem"@cs . "1"^^ . "U pacient\u016F s MDS rozli\u0161ujeme vysoce a n\u00EDzce rizikov\u00E9 MDS s pou\u017Eit\u00EDm mezin\u00E1rodn\u00EDho prognostick\u00E9ho sk\u00F3rovac\u00EDho syst\u00E9mu IPSS. Hlavn\u00EDm probl\u00E9mem je v\u00EDce \u010Di m\u00E9n\u011B symptomatick\u00E1 anemie."@cs . "Treatment of patients with myelodysplastic syndrome with iron overload oral chelator deferasirox"@en . "chelator deferasirox; iron overload; myelodysplastic syndrome"@en . . "1801-1209" . "RIV/00064165:_____/13:10196616" . . "Treatment of patients with myelodysplastic syndrome with iron overload oral chelator deferasirox"@en . "Terapie pacientky s myelodysplastick\u00FDm syndromem s p\u0159et\u00ED\u017Een\u00EDm \u017Eelezem peror\u00E1ln\u00EDm chel\u00E1torem deferasiroxem" . . . "Jon\u00E1\u0161ov\u00E1, Anna" . . "110490" . . . "3"^^ . . "Terapie pacientky s myelodysplastick\u00FDm syndromem s p\u0159et\u00ED\u017Een\u00EDm \u017Eelezem peror\u00E1ln\u00EDm chel\u00E1torem deferasiroxem"@cs . "V" . .